Moreover, overexpressed Elafin in mice is able to enhance the intestinal epithelial barrier and protect against experimental colitis, suggesting that exogenous Elafin could be a potential agent for the treatment of IBD (Motta et al., 2011). Here, PI3 is linked to inflammatory bowel disease.